Influence of the Corneal Collagen Cross-linking on Levels of Il- 1b, Il-6, Il-10 and MMP-2 in the Tear film of Patients with Keratoconus.

The International Journal Of Engineering And Science (IJES)
|| Volume || 6 || Issue || 2 || Pages || PP 27-34 || 2017 ||
ISSN (e): 2319 – 1813 ISSN (p): 2319 – 1805
www.theijes.com The IJES Page 27
Influence of the Corneal Collagen Cross-linking on Levels of Il-
1b, Il-6, Il-10 and MMP-2 in the Tear film of Patients with
Keratoconus.
MD. Karol Krycia1
, Asst Prof. Dorota Wyględowska-Promieńska1,2
,
MD. Łukasz Kulesza1
, PhD. Piotr Gościniewicz1
, PhD. Łukasz Drzyzga1
,
MD. Agata Niedzielska-Krycia1
, PhD. Tomasz Wilczyński1
,
MD. Krzysztof Maria Wilczyński3
1.
Department of Ophthalmology, Prof. K. Gibiński University Clinical Center of Medical University of Silesia in
Katowice, Ceglana 35 street , 40-514 Katowice
2
Clinic and Department of Ophthalmology, Medical University of Silesia, Ceglana 35 street, 40-514 Katowice.
3
Students’ Scientific Society, Department of Ophthalmology, Medical University of Silesia in Katowice, Poland
--------------------------------------------------------ABSTRACT-------------------------------------------------------------
Aim of the study: Evaluation of influence of the corneal collagen cross-linking (CXL) on concentrations of
selected cytokines and metalloproteinase 2 in a tear film. Prospective study with a control group.
Methods: 31 eyes of 31 patients, with confirmed KC, were qualified into the study and underwent a collagen
cross linking procedure. Samples of tear film (100µl) were collected after 6 weeks from the procedure using
spongostan sticks. After centrifugation, the acquired material was tested using high sensitivity ELISA.
Results: In study group before CXL concentrations of IL-1b, IL-6, IL-10, MMP-2 equaled respectively: 151 ±
42, 24 pg/ml, 7,44 ±1,4 pg/ml, 15,88± 2,01 pg/ml, 17,49±2,49 ng/ml. After CXL their levels equaled: 35,32 ±
13,72 pg/ml (p<0,01), 17,73± 5,31 pg/ml (p<0,01), 16,17 ± 2,15 pg/ml (p>0,05), 30,71± 3,88 ng/ml (p<0,01).
There was statistically significant correlation between levels of IL-1b and MMP-2 (r=-0,5; p<0,01).
Conclusions: Outcomes seem to confirm the hypothesis that inflammation is an essential component of
multifactorial etiology of KC. CXL procedure leads to decrease in IL-1b levels and increase in IL-6 and MMP-2
levels in the tear film of patients with KC, after six weeks from procedure. There was a statistically significant
negative correlation between Il-1b and MMP-2. Evaluation of corneal cytokines may be utilized as the
prognostic factor of KC progression.
---------------------------------------------------------------------------------------------------------------------------------------
Date of Submission: 28 November 2016 Date of Accepted: 15 February 2017
--------------------------------------------------------------------------------------------------------------------------------------
I. INTRODUCTION
Keratoconus (KC) is the most common primary corneal ectasia [1]. It is a stromal dystrophy, classified
as a progressive, noninflamatory state characterized by lesions leading to decrease in thickness of central and
pericentral cornea and consequent hallmark “cone-shaped” form [2]. KC is characterized by a distortion of the
biochemical composition of certain corneal layers: a deficit of collagen type VII, XII and VI in the epithelium
and of type I, III, V, VI and XII in the stroma. Progression of a disease leads to the decrease of visual acuity and
in advanced stages to the perforation of a cornea. Estimated occurrence rate of KC is around 1/500-1/2000
people, with no gender differences [3]. First symptoms of conus may appear during adolescence, although the
most acute phase of disease usually develops around the second to third decade of life. In subsequent years, the
disease usually stabilizes, nevertheless the risk of a rapid exacerbation should always be taken into account.
Etiology of the keratoconus remains unclear, although due to the development of diagnostic methods, there is a
growing number of studies trying to establish reliable hypothesis about its etiopathogenesis. Occurrence of KC
is usually linked to the inter allia eye rubbing, atopy, usage of contact lens, genetic predispositions (Down‟s
syndrome, Ehlers-Danlos‟ syndrome, Marfan‟s syndrome) and others. What is more, as the sources in the
literature highlights , there is a significant tendency for KC to coexist with rosacea.
Considering the etiology of keratoconus on a molecular level, particular attention is usually given to the
role of proinflammatory cytokines – interleukins, metalloproteinases and growth factors. Interleukins, produced
by epithelium and mesothelium of a cornea, belong to the group of growth factors stimulating lymphocytes
divisions [4]. Interleukin-1 (Il-1) –occurs in two types: α and β, where the latter one is responsible for most of
the known qualities, inter allia for the modulation of metalloproteinases‟ and collagenases‟ activity. Typical for
KC increased activity of IL-1β leads to lesions in keratocytes and the subsequent apoptosis [5,6,7]. Il-1 is the

Influence of the Corneal Collagen Cross-linking on Levels of Il-1b, Il-6, Il-10 and MMP-2 in the .....
main factor responsible for induction of IL-6 synthesis , which in turn is an essential part of a sequence of events
leading to the chronic inflammation of cornea, the activity of which was found to be increased in course of KC
[4]. An increased level of the abovementioned interleukin was observed in persons liable to frequent
microtraumas of the cornea. Antagonistic effects to the Il-1 are exhibited by Il-10, which plays a major role in
inhibiting inflammatory and immunological reactions [8]
Metalloproteinases of the extracellular matrix (MMP) belong to the group of zinc-dependent
proteolytic enzymes [9]. They are classified as endopeptydases, whose basic function is to participate in the
physiological and pathological processes of remodeling and degradation of the e components of extracellular
matrix. MMP-2 is a key metalloproteinase in cornea [4], it is believed, that its increased levels are responsible
for collagen type IV degradation, and subsequent thinning of corneal tissues, which is a characteristic symptom
of keratoconus.
One of the most common and well established methods of therapy in course of a keratoconus, is a
collagen cross-linking procedure, with application of a riboflavin activated by an ultraviolet radiation – UVA.
Local anesthesia is performed using a proksymetakain hydrochloride solution, and subsequently surgical drapes
and lid dilator are applied. Next, a conjunctival sac is flushed with a 10% solution of a povidon iodine.
Afterwards 8mm abrasion of a corneal epithelium is conducted, with a special attention to leaving the limbus
area intact. In order to minimize the exposition to the UVA radiation reaching the posterior segment of an eye, a
2% pilocarpine hydrochloride is applied. Further steps include infusing cornea with a 0,1% riboflavin in 20%
dextran solution, administered every 2 minutes for 30 minutes. Subsequently cornea is being exposed to UVA
(wave length 365 nm and intensity 3 mW/cm2
) radiation for the next 30 minutes, from a distance of 40 mm with
a simultaneous administration of riboflavin. After the procedure a „band-aid‟ contact lens is applied and anterior
segment is examined with a slit lamp in white and red-free light [10]. The connection of riboflavin and UVA
radiation leads to the creation of additional bonds between collagen fibers [11] which create covalent bonds in
the stroma. This in turn leads to blocking of an irregular astigmatism increase and therefore the decrease in
probability of progression of keratoconus [12]. Conduction of a procedure may prevent the necessity of a
corneal transplantation in the future.
Aim of our study was to evaluate and analyze variations of MMP-2, IL-1β, Il-6, Il-10 levels, before and
after CXL procedure in patients with confirmed keratoconus.
II. MATERIALS AND METHODS
31 eyes of 31 patients with diagnosed keratoconus, admitted to the Prof. K Gibinski University Medical
Center of the Medical University of Silesia, were included into the study and subjected to the collagen cross-
linking procedure. During a qualification process, due to the limited amount of female participants, decision was
made to limit the study group only to males. Average age in group equaled 27 years (min 17; max 44). In all
patients qualified to the control group there were no signs of progression of keratoconus during a whole period
of observation. All participants gave an informed consent for participation in the study, and permission from a
Bioethical Committee of Medical University of Silesia in Katowice was obtained (permission no
20120217).
Inclusion criteria included: age between 15-45 years, ophthalmological examination consisting of interview,
refraction, visual acuity with and without best optical correction, examination of the anterior and posterior
segment of an eye in slit lamp, intraocular pressure measured using Goldman‟s aplanation tonometer and
corneal topography performer using Cornea/Anterior segment OCT SS-1000 manufactured by TOMEY, in
purpose of clinical confirmation of keratoconus. Qualification of patients into groups was performed based on
similarity of a clinical stage of the disease (early (I) and moderate (II) stage according to the Krumeich and
Amsler‟s scale (tab. 1)), topographical (Ks (the steepest meridian) and Kf (the most flat meridian)) and
pachymetric parameters (the minimum pachymetry atop the cone at least 400 µm). Thickness of cornea on the
top of the cone was the most important factor conditioning safety during CXL. Exclusion criteria included: age
below 15 or above 45, inflammatory diseases precluding from sample collection, state after refraction surgery,
scarring of a cornea, state after inflammation of anterior or posterior segment of a vascular membrane, state after
ocular trauma, pseudophakia, pregnancy and breastfeeding.
Table 1. Amsler‟s and Krumeich‟s classification of keratoconus.
Amsler‟s and Krumeich‟s classification of keratoconus
Stage Refractive error
(myopia and/or
astigmatism)
Corneal curvature
radius (average
central value K)
Notes Minimal cornea
thickness (pachymetry)
I <5 D <48 D Off-axis cornea convex,
Vogt lines present,
no cornea scarring
>460 µm
II 5-8 D 48-53 D Vogt lines present,
no cornea scarring
400-460 µm
III 8-10 D 53-55 D Vogt lines present, 200-400 µm

no cornea scarring
IV Unable to measure
refractive terror
>55 D Sparring in the central part of the cornea,
Perforation of the cornea
<200 µm
Samples of a tear film were collected twice. Tear liquid volume of at least 100 µl, was acquired by
placing 3 spongostan sticks in a conjunctival sac for a period of 2 minutes. First sample was collected directly
before CXL, and second one 6 weeks after procedure. Upon removal of spongostan sticks, 10% Sulfacetamidum
Natricium antibiotic drops were administered to the conjunctival sac as an anti-inflammatory prophylaxis.
Acquired material was separated directly after collection by centrifugation lasting 5 minutes, with a speed of
10000 rotations per minute, using a Centrifuge MPW-300 (MPW Med. Instruments Poland) device.
Subsequently elicted biological material was stored in -20o
C. After administration of a local anesthesia, using a
proksymetakain hydrochloride solution, and following application of surgical drapes and lid dilator, the
conjunctival sac was flushed with a 10% solution of a povidon iodine. Afterwards an 8mm abrasion of a corneal
epithelium was conducted, with a special attention to leaving the limbus area intact. In order to minimize the
exposition to the UVA radiation reaching the posterior segment of an eye, a 2% pilocarpine hydrochloride was
applied. Further steps included infusion of cornea with a 0,1% riboflavin in 20% dextran solution, administered
every 2 minutes for 30 minutes. Subsequently cornea was being exposed to UVA (wave length 365 nm and
intensity 3 mW/cm2
) radiation for the next 30 minutes, from a distance of 40 cm with a simultaneous
administration of riboflavin. After the procedure a „band-aid‟ contact lens was applied and anterior segment was
examined with a slit lamp in white and red-free light [10].Postoperative treatment was applied to all participants
undergoing CXL procedure, including application of “band-aid” contact lens (Alcon) for a period of 1 week and
administration of an antibiotic prophylaxis (Levofloxacinum 5 mg/ml manufactured by Santen OY) 4 times a
day. One week after procedure, “band-aid” contact lens were removed, and Dexamethason 1 mg/ml
(Laboratories Thea) drops were applied for a period of 4 weeks, with administration frequency of 3 times a day,
decreasing by one each week. Moisturizing drops Cationorm (Santen OY) and regenerating ointment Corneregel
50 mg/ml (Dr. Gerhard Mann Chem-Pharm. Fabrik VP Valeant) were applied for the whole postoperative
period. 6 weeks after collection of the first sample, complete ophthalmological examination was conducted,
including the same procedures as during inclusion into study. Each 100 µl sample of a tear liquid was divided
into 20 µl portions, and diluted with 100 µl of a solvent included into the test kit, in order to conduct evaluation
of levels of IL-1β, Il-6, Il-10 and MMP-2 contained in a sample. The dilution factor was taken into account
during a statistical analysis. All biochemical procedures were conducted using a Diaclone 450 nm (0,1s)
quantitive reader to a high-sensitivity ELISA and Kit Human tests.
Statistical analysis was conducted using commercially available software GraphPad Prism 6. Accepted
level of significance equaled α=0,05. Data was prepared for further analysis using a Kolmogorov-Smirnov‟s
test and D‟Agostino& Pearson omnibus test. Standard deviation and average was calculated. In order to
compare outcomes between groups, Wilcoxon signed rank test, Mann-Whitney‟s U test and Dunn‟s multiple
comparison tests were applied.
III. OUTCOMES
31 patients with diagnosed keratoconus participated in the study (tab. 2). Il-1β, IL-6, IL-10 and MMP-2
levels in material obtained from a conjunctival sac were analyzed using high sensitivity ELISA, and outcomes
are presented in a table number 3.
In all patients, Il-1β level was significantly decreased after 6 weeks period of observation, in
comparison to values obtained before CXL (p<0,01) [pic. 1]. Inversely in case of Il-6 a statistically significant
raise in concentrations was observed in a follow-up period (p<0,05) [pic. 2]. There were no statistically
significant differences in concentrations of Il-10 [pic. 3]. Analysis of MMP-2 concentrations in tear film
revealed major, statistically significant increase in patients after CXL in comparison to samples acquired before
procedure [pic. 4]. In course of a statistical analysis, a significant negative correlation has been found between
concentrations of Il-1β and MMP-2 in a tear film acquired from patients who underwent the CXL procedure (r=-
0,5; p<0,01) [pic. 5]. There was no statistically significant correlation between increase in IL-6 concentrations
and MMP-2 in patients in follow-up period.
IV. DISCUSSION
Selection of cytokines included into a biochemical analysis was based on their properties. Il-1β and Il-6
were selected due to the strongest proinflammatory qualities, and Il-10 due to its anti-inflammatory properties.
Data available in literature highlights a significance of MMP-9 in corneal remodeling. MMP-2, belonging to the
same group of gelatinases, was included into analysis.
Despite plenty of publications describing role of inflammatory mediators in a pathogenesis of the
keratoconus, data about influence of particular cytokines on a progression of KC is still limited. Acquired data

revealed that CXL significantly decreases concentrations of Il-1β, increases levels of Il-6 and MMP-2, whereas
does not affect Il-10 concentrations. Elevated concentrations of Il-6 may be related to the presence of a
significant local inflammatory reaction, what was revealed by Gavis[2], Shetty[13], Jun[14], Lema [15,16] in
their studies, which compared its levels in healthy subjects and patients with the keratoconus. This hypothesis
was also supported by Sarkhabi et al [17]. Aforementioned considerations were widened by Wojcik et al. [4]
revealing further increase of Il-6 concentration during an exacerbation of keratoconus. Significant data was also
provided by Becker et al.[18] who observed a considerable elevation of Il-6 level in ulcerated corneas in
comparison to corneas with scarring or dystrophy. Other hypothesis trying to explain etiology of the
keratoconus, states that it may be caused by microtraumas resulting from for example forceful eye rubbing or
wearing contact lenses. Mechanical damage caused by microtraumas may affect Il-6 levels, increasing the risk
of development of keratoconus. Balasubramanian et al. [19] revealed a significant elevation in Il-6
concentrations after 60 seconds of eye rubbing by healthy volunteers. Confirmation of an aforementioned
hypothesis may also be found in outcomes of a study conducted by Wilson et al. [20] who revealed 2-40 times
higher concentrations of proinflammatory cytokines, such as Il-6, in people using contact lenses. Among
surgical procedure aiming to slow down or stop the progression of keratoconus, CXL is considered to be a
golden standard. Therefore it was of the interest how it affects Il-6 concentrations. Kolozsvari et al. [1]
evaluated influence of CXL on levels of cytokines in tear film of patients with KC, to date it was first and only
publication on this issue. They revealed statistically significant increase in Il-6 level on a fourth day after
intervention, and decrease in its concentration after six months of observation. Kolozsvari et al. allotted an
annual observation period in their study. In reference to our results it can be stated that decrease in Il-6
concentration occurs at least six weeks after the procedure. Postoperative pharmacotherapy in aforementioned
study differed from a treatment administered in our center. Patients in our study used steroidal drops over the
period of 4 weeks, while participants of Kolozsvari‟s project for 3 months. Noted was a statistically significant
increase of he analyzed mediator that persisted 6 weeks after the CXL procedure.
Elevated levels of Il-1 in patients with an inflammation of the cornea were first noticed by Becker et al.
[21], who compared its concentrations in tear film of patients with an inflammation and with scarring of the
cornea. Sarkhabi et al. [17] revealed increased levels of Il-1β in tear film of patients with diagnosed
keratoconus. In our study, obtained concentrations of Il-1β were considerably higher than Sarkhabi‟s, and its
level diminished after CXL procedure. This observation implies that Il-1 is an essential factor in pathogenesis of
KC, and supports inflammatory hypothesis. Moreover, data obtained in our study reveals that the more
advanced stage of keratoconus is, the higher Il-1 concentration in the tear film is. Significance of microtraumas
in pathogenesis of KC may be confirmed by an elevation of Il-1 concentrations in the tear film of patients with
mechanical damage to the corneal epithelium [20]. Keratocytes in patients with KC have four times higher
amount of Il-1 receptors [22]. In the same time Il-1 is a modulator of keratocyte proliferation, differentiation and
apoptosis. Its increased emission was observed during microtraumas of the epithelium.
In patients with rosacea, an elevated expression of genes from Il-1 family was confirmed. Due to that, widely
brought up in a literature issue, of the coexistence of the rosacea and the keratoconus, seems to be especially
interesting. Currently numerous studies, aiming at description of a polymorphism for Il-1β gene present in
patients with KC, are being conducted worldwide [23, 24, 25,26,27]. Results obtained in our study reveal
decrease in IL-1 concentrations after CXL, what may stand for the efficacy of the CXL procedure in
keratoconus treatment.
Mascai et al. [3] and Lema et al. [18] in an attempt to confirm the participation of the corneal
microtrauma in pathogenesis of KC, examined the tear film cytokines concentrations of people using contact
lenses. Data obtained by them, reveals 8 times higher level of anti-inflammatory interleukin 10. Sorkhabi et al.
[17] focusing on comparisons of the tear film composition in patients with KC and healthy controls, found out a
decreased concentration of Il-10 in patients. Data obtained in our study, in patients with KC who underwent
CXL procedure and in control group, revealed no statistically significant difference. Levels of Il-10 requires
further research, focusing on their shifts and participation in pathogenesis of KC and other inflammatory
diseases of anterior segment of an eye.
Balasubramanian et al.[29] revealed increase in MMP-1, -3, -7, -13 in the tear film of patients with
keratoconus. Similar results were publish by inter allia Jun [14] and Lema [16,18]. In their study, Wójcik et al.
[4] point out that increase in MMP activity, observed in course of KC, probably leads to the degradation of an
extracellular matrix leading to thinning of corneal tissues. Elevated levels of MMP-2 may be explained by an
apoptosis of keratocytes and appearance of additional bonds between collagen fibers, aiming to stabilize
spherical shape of cornea. In a following study, we observed increased levels of MMP-2 in the tear film of
patients with KC six weeks after the CXL procedure. Taking into account the fact that MMP-2 belongs to the
same family as MMP-9, and exhibit similar properties and functions, outcomes obtained by Shetty et al. [13]
seem to be relevant in reference to our results. In their study, Shetty et al. observed patients with KC over the
period of 6 months, during pharmacotherapy with a Cyclosporine A. Data obtained in course of their research,

revealed decrease in MMP-9 levels in the tear film of patients, and subsequent stabilization of a clinical
condition. Therefore the administration of Cyclosporine A directly after CXL procedure seems to be
inadvisable as it may disturb the remodeling and hardening of the stroma of the cornea. In the future, the
evaluation of MMP-2 concentrations may be utilized as a prognostic factor for assessment of CXL outcomes.
V. CONCLUSIONS
Following study confirms inflammatory hypothesis in multifactorial pathogenesis of KC. CXL
procedure leads to the decrease of IL-1β concentrations, increase in Il-6 and MMP-2 levels and does not affect
Il-10 level. There was a statistically significant negative correlation between Il-1β and MMP-2. Subsequently to
the conducted CXL procedure, inflammatory reaction subsided and concentrations of MMP-2, responsible for
remodeling of a cornea, increased. In our opinion evaluation of Il-1β concentrations, as a main proinflammatory
cytokine affecting the corneal pathology, should be continued. Assessment of proinflammatory cytokines may
be utilized as a prognostic factor of a progression of keratoconus.
Table. 2 Patients which participated in the study
N Age Maximum age Minimum age Males
31 27 64 17 31 (100%)
Study Stydy after 6 weeks
IL-1beta
Mean [pg/ml] 151 35,32
Std. Deviation 235,2 76,38
Std. Error 42,24 13,72
KS distance 0,2711 0,3301
P value < 0,0001 < 0,0001
IL -6
Mean [pg/ml] 7,439 17,73
Std. Error 1,415 5,314
P value 0,0194 < 0,0001
IL-10
Mean [pg/ml] 15,88 16,17
Std. Error 2,011 2,15
P value > 0,10 0,0023
MMP-2
Mean [ng/ml] 17,49 30,71
Std. Error of Mean 2,491 3,882
P value 0,0243 > 0,1000
Table 3. Obtained levels of cytokines and MMP-2.
Pic.1 Difference in concentrations of IL-1β before and after CXL procedure.

Pic.2 Difference in concentrations of IL-6 before and after CXL procedure.
Pic 3. Difference in concentrations of IL-10 before and after CXL procedure.
Pic 4. Difference in concentrations of MMP-2 before and after CXL procedure.

Pic 5. Correlation between concentrations of MMP-2 and Il-1.
BIBLIOGRAPHY
[1]. Kolozsvári BL, Berta A, Petrovski G, Miháltz K, Gogolák P, Rajnavölgyi E, Hassan Z, Széles P, Fodor M.:”Alterations of tear
mediators in patients with keratoconus after corneal crosslinking associate with corneal changes.”;PLoS One. 2013;8(10):e76333.
doi: 10.1371/journal.pone.0076333. eCollection 2013.
[2]. Galvis V1, Sherwin T2, Tello A1, Merayo J3, Barrera R4, Acera A5.: “Keratoconus: an inflammatory disorder?”; Eye (Lond).
2015; 29(7):843-59. doi: 10.1038/eye.2015.63. Epub 2015 May 1.
[3]. Macsai MS, Varley GA, Krachmer JH.:“Development of keratoconus after contact lenswear: Patient characteristics.”; Arch
Ophthalmol 1990;108:534-8.
[4]. Wojcik KA , Blasiak J , Szaflik J , Szaflik JP:“Faculty of Biology and Environmental Sciences, Department of Molecular Genetics,
University of Lodz, Łódź, Poland.”; Acta Biochimica Polonica 2014; 61(1):55-62
[5]. Wilson SE, He YG, Lloyd SA: “EGF, EGF receptor, basic FGF, TGF beta-1, and interleukin-1alpha mRNA in human corneal
epithelial cells and stromal fibroblasts.”; Invest Ophthalmol Vis. Sci 2012; 33:1756–1765.
[6]. Wilson SE, He YG, Weng J, Li Q, McDowall AW, Vital M, Chwang EL: “Epithelial injury induces keratocyte apoptosis: hypothe-
sized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing.”; Exp Eye Res 1996; 62:
325–327.
[7]. Wise R, Wilson SE, He YG, Weng J: “Interleukin-1 alpha induces apoptosis in human corneal stromal fibroblast cells.”; Invest
Ophthalmol Vis Sci 1994; 35: 1980.
[8]. Grunauer-Kloevekorn C, Duncker G.I: Keratoconus: “Epidemiology, risk factors and diagnosis.”; Klin Monl Augenheilkd. 2006;
223(6):493-502
[9]. Wasiliewska A.:“Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology.”; Przegląd Lekarski
2009; 66(9)
[10]. Kucharzewski P.: „Analysis of the morphology of the cornea using confocal microscopy in vivo in patients with keratoconus after
surgery crosslinking of collagen fibers”; SUM 2012: p34
[11]. Dahl B, Spotts E, Truong J:“Corneal collagen cross-linking: An introduction and literature review.”; Optometry 2012; 83: 33-42.
[12]. Mirko R, Jankov II, Jovanovic V, Nikolic L, . Lake JC, Kymionis G, Coskunseven E.: “Corneal Collagen Cross-Linking.”; Middle
East Afr J Ophthalmol. 2010; 17(1)
[13]. Shetty R, Ghosh A, Lim RR, Subramani M, Mihir K, Reshma AR, Ranganath A, Nagaraj S, Nuijts RM, Beuerman R, Shetty R, Das
D, Chaurasia SS, Sinha-Roy A, Ghosh A.: “Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in
keratoconus patients is inhibited by cyclosporine”;Invest Ophthalmol Vis Sci. 2015;56(2):738-50. doi: 10.1167/iovs.14-14831.
[14]. Jun AS, Cope L, Speck C, Feng X, Lee S, Meng H, Hamad A, Chakravarti S.: “Subnormal cytokine profile in the tear fluid of
keratoconus patients.”;PLoS One.2011;6(1):e16437. doi: 10.1371/journal.pone.0016437.
[15]. Lema I, Sobrino T, Durán JA, Brea D, Díez-Feijoo E.: “Subclinical keratoconus and inflammatory molecules from tears.”; Br J
Ophthalmol. 200;93(6):820-4. doi: 10.1136/bjo.2008.144253
[16]. Lema I, Durán JA.: “Inflammatory molecules in the tears of patients with keratoconus.”; Ophthalmology. 2005;112(4):654-9.
[17]. Sorkhabi R, Ghorbanihaghjo A, Taheri N, Ahoor MH: ”Tear film inflammatory mediators in patients with keratoconus.”; Int
Ophthalmol. 201;35(4):467-72. doi: 10.1007/s10792-014-9971-3
[18]. Lema I, Durán JA, Ruiz C, Díez-Feijoo E, Acera A, Merayo J.:“Inflammatory response to contact lenses in patients with
keratoconus compared with myopic subjects. Cornea 2008;27:758–63.
[19]. Balasubramanian SA, Pye DC, Willcox MD.: “Effects of eye rubbing on the levels of protease, protease activity and cytokines in
tears: relevance in keratoconus.”; Clin Exp Optom. 2013;96(2):214-8. doi: 10.1111/cxo.12038.
[20]. Wilson SE, He YG, Weng J, Li Q, McDowall AW, Vital M, et al.:“Epithelial injury induces keratocyte apoptosis: hypothesized role
for the interleukin-1 system in the modulation of corneal tissue organization and wound healing.”; Exp Eye Res 1996;62:325–37.
[21]. Becker J., Salla S., Dohmen U., Redbrake C., Reim M. Explorative study of interleukin levels in human cornea. Graefes Arch Clin
Exp Ophthalmol 1995; 233(12):766-771
[22]. Bereau J, Fabre EJ, Hecquet C, Pouliquen Y, Lorans G.:“Modification of prostaglandin E2 and collagen synthesis in keratoconus
fibroblasts associated with an increase of interleukin-1 alpha receptor number.”; CR Acad Sci III 1993;316:425–30.
[23]. Wang Y, Wei W, Zhang C, Zhang X, Liu M, Zhu X, Xu K.: “Association of Interleukin-1 Gene Single Nucleotide Polymorphisms
with Keratoconus in Chinese Han Population.”; Curr Eye Res. 2015; 22:1-6.
[24]. Mikami T1, Meguro A, Teshigawara T, Takeuchi M, Uemoto R, Kawagoe T, Nomura E, Asukata Y, et. al: “Interleukin 1 beta
promoter polymorphism is associated with keratoconus in a Japanese population.”; Mol Vis. 2013; 19:845-51

[25]. Wygledowska-Promieńska D: “Present views concerning surgery treatment of keratoconus.”; Klin Oczna. 2005;107(7-9):525- 8.
[26]. Wygledowska-Promieńska D, Zawojska I.: “Procedure for keratoconus detection according to the Rabinowitz-Rasheed method--
personal experience.”; Klin Oczna. 2000;102(4):241-4.
[27]. Wygledowska-Promieńska D, Zawojska I.: “Use of AutoTopograf TMS-3 keratoconus screening program for keratoconus
detection.”; Klin Oczna. 2000;102(4):237-40.
[28]. Balasubramanian SA, Mohan S, Pye DC, Willcox MD.: “Proteases, proteolysis and inflammatory molecules in the tears of people
with keratoconus.”; Acta Ophthalmol. 2012;90(4):e303-9. doi: 10.1111/j.1755-3768.2011.02369.x.
Pic 1. Difference in concentrations of IL-1β before and after CXL procedure.
Pic 4. Difference in concentrations of MMP-2 before and after CXL procedure.
Pic 5. Correlation between concentrations of MMP-2 and Il-1.
Table 1. Table 1 Amsler’s and Krumeich’s classification of keratoconus.
Table 2. Patients which participated in the study.
Table 3 Obtained levels of cytokines and MMP-2.

Influence of the Corneal Collagen Cross-linking on Levels of Il- 1b, Il-6, Il-10 and MMP-2 in the Tear film of Patients with Keratoconus.

More Related Content

What's hot

Viewers also liked

Similar to Influence of the Corneal Collagen Cross-linking on Levels of Il- 1b, Il-6, Il-10 and MMP-2 in the Tear film of Patients with Keratoconus.

Recently uploaded

Influence of the Corneal Collagen Cross-linking on Levels of Il- 1b, Il-6, Il-10 and MMP-2 in the Tear film of Patients with Keratoconus.